Home > National Drug Code (NDC) > HYLENEX Recombinant

HYLENEX Recombinant - 18657-102-04 - (Hyaluronidase (Human Recombinant))

Alphabetical Index


Drug Information of HYLENEX Recombinant

Product NDC: 18657-102
Proprietary Name: HYLENEX Recombinant
Non Proprietary Name: Hyaluronidase (Human Recombinant)
Active Ingredient(s): 150    [USP'U]/mL & nbsp;   Hyaluronidase (Human Recombinant)
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of HYLENEX Recombinant

Product NDC: 18657-102
Labeler Name: Halozyme, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021859
Marketing Category: NDA
Start Marketing Date: 20051202

Package Information of HYLENEX Recombinant

Package NDC: 18657-102-04
Package Description: 4 BOX in 1 CARTON (18657-102-04) > 1 VIAL in 1 BOX (18657-102-02) > 1 mL in 1 VIAL (18657-102-01)

NDC Information of HYLENEX Recombinant

NDC Code 18657-102-04
Proprietary Name HYLENEX Recombinant
Package Description 4 BOX in 1 CARTON (18657-102-04) > 1 VIAL in 1 BOX (18657-102-02) > 1 mL in 1 VIAL (18657-102-01)
Product NDC 18657-102
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Hyaluronidase (Human Recombinant)
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20051202
Marketing Category Name NDA
Labeler Name Halozyme, Inc.
Substance Name HYALURONIDASE (HUMAN RECOMBINANT)
Strength Number 150
Strength Unit [USP'U]/mL
Pharmaceutical Classes Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient]

Complete Information of HYLENEX Recombinant


General Information